Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05366153
Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
Sponsor: Baker Heart and Diabetes Institute
View on ClinicalTrials.gov
Summary
REDEEM-CAD is a prospective multi-centre study of CAD risk evaluation and management in cancer survivors 40-70 years with chemotherapy or radiotherapy \>5 years ago.
Official title: Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer (REDEEM-CAD)
Key Details
Gender
All
Age Range
40 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
748
Start Date
2023-10-18
Completion Date
2026-05
Last Updated
2025-12-04
Healthy Volunteers
Yes
Conditions
Interventions
DIAGNOSTIC_TEST
Coronary CT
Screening/Management Plan
Locations (2)
Tom Marwick
Hobart, Tasmania, Australia
Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia